OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Synergism between anti-angiogenic and immune checkpoint inhibitor drugs: A hypothesis
Ajit Venniyoor
Medical Hypotheses (2020) Vol. 146, pp. 110399-110399
Closed Access | Times Cited: 7
Ajit Venniyoor
Medical Hypotheses (2020) Vol. 146, pp. 110399-110399
Closed Access | Times Cited: 7
Showing 7 citing articles:
Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma
Daniela Gabbia, Sara De Martin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3441-3441
Open Access | Times Cited: 22
Daniela Gabbia, Sara De Martin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3441-3441
Open Access | Times Cited: 22
Anti‐angiogenic therapy enhances cancer immunotherapy: Mechanism and clinical application
Anqi Li, Jian‐Hong Fang
Deleted Journal (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 7
Anqi Li, Jian‐Hong Fang
Deleted Journal (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 7
Hepatocellular Carcinoma: Pick the Winner—Tyrosine Kinase Inhibitor Versus Immuno-oncology Agent–Based Combinations
Anthony Bejjani, Richard S. Finn
Journal of Clinical Oncology (2022) Vol. 40, Iss. 24, pp. 2763-2773
Closed Access | Times Cited: 28
Anthony Bejjani, Richard S. Finn
Journal of Clinical Oncology (2022) Vol. 40, Iss. 24, pp. 2763-2773
Closed Access | Times Cited: 28
Comparing PD ‐L1 and PD ‐1 inhibitors plus bevacizumab combined with hepatic arterial interventional therapies in unresetable hepatocellular carcinoma: A single‐center, real‐world study
Minrui He, Wa Xie, Ze Yuan, et al.
International Journal of Cancer (2025)
Closed Access
Minrui He, Wa Xie, Ze Yuan, et al.
International Journal of Cancer (2025)
Closed Access
Combination of Immune Checkpoint Inhibitors and Anti-Angiogenic Agents in Brain Metastases From Non-Small Cell Lung Cancer
Likui Fang, Wuchen Zhao, Bo Ye, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18
Likui Fang, Wuchen Zhao, Bo Ye, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18
High tumor mutational burden assessed through next-generation sequencing predicts favorable survival in microsatellite stable metastatic colon cancer patients
Annabella Di Mauro, Mariachiara Santorsola, Giovanni Savarese, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Annabella Di Mauro, Mariachiara Santorsola, Giovanni Savarese, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Polypharmacy in the elderly on immunotherapy: Problem or opportunity?
Ajit Venniyoor
Cancer Research Statistics and Treatment (2021) Vol. 4, Iss. 3, pp. 583-584
Open Access | Times Cited: 2
Ajit Venniyoor
Cancer Research Statistics and Treatment (2021) Vol. 4, Iss. 3, pp. 583-584
Open Access | Times Cited: 2
